The concepts and features that will enable Cloud ALM to meet the regulatory requirements for the pharmaceutical and medical industry were also presented at the Summit. This is encouraging for two reasons:
At the beginning of the year, SAP hosted a workshop to discuss precisely what industry customers require from the future ALM solution. Representatives from XEPTUM participated in this workshop and used their expertise to make significant contributions to future features and concepts. Specifically, the requirements around digital signatures and their integration into ALM processes were discussed. However, according to the latest information available, SAP will not provide a digital signature feature. XEPTUM will therefore provide solutions for this functional gap in Cloud ALM.
Secondly, SAP demonstrated a strong customer focus and a high degree of transparency. Not only did SAP outline its future plans for Cloud ALM, but they also invited the community of partners and end customers to help shape this path. It was therefore all the more satisfying to see that SAP had given consideration to many of the points and features discussed at the workshop and was able to present a promising roadmap for customers in the pharmaceutical and medical industry at the Summit.
We, at XEPTUM, continue to closely follow the development of Cloud ALM, especially for end customers in the GxP environment, and we look forward to keeping you up to date on Cloud ALM.
